Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115260080B reveals efficient one-step carbonylation. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical intermediates.
Novel palladium-catalyzed carbonylation route offers high purity pharmaceutical intermediates with scalable cost reduction and supply chain reliability.
Patent CN112341468A reveals a novel copper-catalyzed route to azetidino-1,4-benzodiazepines, offering high yields and streamlined functionalization for API manufacturing.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering reliable pharmaceutical intermediate supply and simplified purification.
Novel metal-free method for trifluoroacetimide-substituted dihydrobenzofuran. Enhances purity and supply chain stability for pharmaceutical intermediates globally.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of bioactive heterocycles.
Patent CN113045489B details a novel Pd-catalyzed route for quinolin-2(1H)ones, offering cost-effective API intermediate manufacturing with high functional group tolerance.
Novel patent CN114195711B offers efficient quinoline-4(1H)-one synthesis. Reduces costs and improves supply chain reliability for pharmaceutical intermediates.
Patent CN103664821B reveals mild protonic acid catalysis for benzothiazole. Offers cost reduction and supply reliability for pharma intermediates.
Novel metal-free oxidative cyclization route for high-purity pharmaceutical intermediates. Reduces synthetic steps and eliminates heavy metal contamination risks.
Patent CN113307790B reveals a metal-free oxidative cyclization route for 3-quinolyl-5-trifluoromethyl-1,2,4-triazoles, offering cost reduction in API manufacturing and scalable production.
Patent CN112480015B reveals an efficient Pd-catalyzed route for high-purity quinazolinone intermediates, offering significant cost and supply chain advantages.
Patent CN112125856A reveals a safe Pd-catalyzed carbonylation route for quinazolinone derivatives, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediates.
Efficient iron-catalyzed synthesis of pyrrolo[1,2-a]indole alkaloids via C-H/N-H activation. Mild conditions, high yield, scalable process for pharma intermediates.
Patent CN112480015B details a novel Pd-catalyzed one-pot synthesis for 2-trifluoromethyl quinazolinones, offering significant cost reduction and supply chain advantages for pharmaceutical intermediates.
Novel copper-catalyzed route for polyfluoroalkyl indolines. Reduces cost vs palladium methods. High purity pharmaceutical intermediates available.
Patent CN102040564B reveals a safe, high-yield nucleophilic substitution route for 3-aminobenzo[d]isothiazole, offering significant cost reduction and supply chain stability for pharma manufacturing.
Patent CN113801050A reveals a copper-catalyzed method for highly functionalized beta-lactams, offering cost reduction in pharmaceutical intermediate manufacturing and scalable production.
Patent CN109134351B details a novel synthesis of S-3-(4-aminophenyl)piperidine with >99% ee, offering cost-effective scalability for PARP inhibitor manufacturing.